1. Search Result
Search Result
Results for "


" in MCE Product Catalog:
Cat. No. Product Name Target Research Areas
  • HY-10528


    HDAC Cancer
    Tasquinimod is an oral antiangiogenic agent, which has the potential for castration-resistant prostate cancer treatment. Tasquinimod binds to the regulatory Zn 2+ binding domain of HDAC4 with Kd of 10-30 nM. Tasquinimod also is a S100A9 inhibitor.